Nanchang University Queen Mary School, Nanchang, Jiangxi, 330031, China.
Department of Endocrinology, The Second Hospital of Shandong University, Jinan, Shandong, 250033, China.
Clinics (Sao Paulo). 2020;75:e1486. doi: 10.6061/clinics/2020/e1486. Epub 2020 Mar 13.
Previous studies have not shown any correlation between bile acid metabolism and bone mineral density (BMD) in women with postmenopausal osteoporosis. Thus, the current study evaluated the association between bile acid levels as well as BMD and bone turnover marker levels in this group of women.
This single-center cross-sectional study included 150 postmenopausal Chinese women. According to BMD, the participants were divided into three groups: osteoporosis group, osteopenia group, and healthy control group. Serum bile acid, fibroblast growth factor 19 (FGF19), and bone turnover biomarker levels were assessed. Moreover, the concentrations of parathyroid hormone, 25-hydroxy vitamin D [25(OH)D], procollagen type I N-peptide (P1NP), and beta-CrossLaps of type I collagen containing cross-linked C-terminal telopeptide (β-CTX) were evaluated. The BMD of the lumbar spine and proximal femur were examined via dual-energy X-ray absorptiometry.
The serum total bile acid levels in the osteoporosis and osteopenia groups (5.28±1.56 and 5.31±1.56 umol/L, respectively) were significantly lower than that in the healthy control group (6.33±2.04 umol/L; p=0.002 and 0.018, respectively). Serum bile acid level was positively associated with the BMD of the lumbar spine, femoral neck, and total hip. However, it negatively correlated with β-CTX concentration. Moreover, no correlation was observed between bile acid and P1NP levels, and the levels of the other biomarkers that were measured did not differ between the groups.
Serum bile acid was positively correlated with BMD and negatively correlated with bone turnover biomarkers reflecting bone absorption in postmenopausal women. Thus, bile acid may play an important role in bone metabolism.
先前的研究并未显示绝经后骨质疏松症女性的胆汁酸代谢与骨密度(BMD)之间存在任何相关性。因此,本研究评估了该组女性胆汁酸水平以及 BMD 和骨转换标志物水平之间的关系。
这项单中心横断面研究纳入了 150 名绝经后中国女性。根据 BMD,将参与者分为三组:骨质疏松组、骨量减少组和健康对照组。评估了血清胆汁酸、成纤维细胞生长因子 19(FGF19)和骨转换生物标志物水平。此外,还评估了甲状旁腺激素、25-羟维生素 D [25(OH)D]、I 型前胶原 N 端肽(P1NP)和 I 型胶原交联 C 端肽(β-CTX)的浓度。通过双能 X 射线吸收法检查腰椎和股骨近端的 BMD。
骨质疏松症和骨量减少症组(分别为 5.28±1.56 和 5.31±1.56 umol/L)的血清总胆汁酸水平明显低于健康对照组(6.33±2.04 umol/L;p=0.002 和 0.018)。血清胆汁酸水平与腰椎、股骨颈和全髋关节的 BMD 呈正相关,但与 β-CTX 浓度呈负相关。此外,胆汁酸与 P1NP 水平之间无相关性,所测量的其他生物标志物的水平在各组之间无差异。
血清胆汁酸与 BMD 呈正相关,与反映骨吸收的骨转换标志物呈负相关。因此,胆汁酸可能在骨代谢中发挥重要作用。